Overall survival tended to be better among these patients than among patients positive for 53BP1, but the difference did not achieve significance (Fig. 6c ).
← all excerpts
53BP1 depletion causes PARP inhibitor resistance in ATM-deficient breast cancer cells.
1
—
—